Anika Reports Second Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Anika Therapeutics (ANIK) Tops Q2 EPS by 13c
July 27, 2016 5:18 PM EDTAnika Therapeutics (NASDAQ: ANIK) reported Q2 EPS of $0.57, $0.13 better than the analyst estimate of $0.44. Revenue for the quarter came in at $26.6 million versus the consensus estimate of $24.75 million.
We continued our strong momentum in the second quarter, with total revenue growth of 16% year-... More
